225220 — Genolution Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Genolution, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	32,046	34,394	14,602	-5,550	-7,209
Depreciation
Amortisation
Non-Cash Items	23,677	7,183	2,054	450	1,727
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,245	-16,890	-4,433	2,387	2,009
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	45,971	25,732	13,551	-1,136	-1,433
Capital Expenditures	-9,551	-5,131	-22,545	-6,883	-12,186
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8,750	-17,943	-28,912	-195	37,874
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-18,300	-23,074	-51,457	-7,078	25,688
Financing Cash Flow Items	—	—	—	238	560
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	15,346	-15,092	9,150	7,159	373
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	40,340	-10,040	-26,615	-1,217	26,091